Long Run Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Long Run Wealth Advisors's PFE Position: Q4 2025 in Review
Long Run Wealth Advisors increased its Pfizer (PFE) stake by 1.1% in Q4 2025, buying an estimated $19.3K and bringing the position to 69,160 shares worth $1.72M. The position accounts for 0.32% of the portfolio, ranked #53.
Long Run Wealth Advisors first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.74M in Q3 2025. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Long Run Wealth Advisors held 69,160 shares of Pfizer worth $1.72M as of Q4 2025.
- Long Run Wealth Advisors bought 764 Pfizer shares in Q4 2025, an estimated $19.3K.
- Pfizer made up 0.32% of Long Run Wealth Advisors's portfolio in Q4 2025, its #53 holding.
- Long Run Wealth Advisors first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
- Long Run Wealth Advisors's Pfizer position peaked at $1.74M in Q3 2025.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Long Run Wealth Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.